BioPharm News

Feb 27, 2015
By BioPharm International Editors
FDA announced that it would postpone a meeting that would be critical for the advancement of Celltrion’s Remicade biosimilar in the US.
BioPharm International: Feb 25, 2015
Remsima will now be available for patients in 12 additional countries in the European Union.
BioPharm International: Feb 24, 2015
By BioPharm International Editors
Drug shortages are declining, but they’re still a serious concern for regulatory authorities, policy makers, and bio/pharmaceutical manufacturers.
BioPharm International: Feb 24, 2015
By BioPharm International Editors
Baxter announced that its new biopharmaceutical arm, scheduled to become independent from Baxter in 2015, will be located in Bannockburn, Illinois.
BioPharm International: Feb 24, 2015
By BioPharm International Editors
The company voluntarily recalls product due to FDA observations of potential sterility problems.
BioPharm International: Feb 23, 2015
By BioPharm International Editors
The agency cites Apotex’s Bangalore facility with quality system failures.
Feb 23, 2015
By BioPharm International Editors
Leased facilities in California will expand Kite Pharma's capacity for T-cell therapies.
BioPharm International: Feb 20, 2015
By BioPharm International Editors
The Patent and Trademark Office sends notice rejection of the company’s Remicade patent.
BioPharm International: Feb 20, 2015
MedImmune will provide funds and access to monoclonal antibodies to seven postdoctoral associates for the creation of protein measurement and characterization tools.
BioPharm International: Feb 20, 2015
By BioPharm International Editors
The agency is enlisting members of European pharmaceutical associations and industry representatives to participate in IDMP task force.